{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:45:23Z","timestamp":1792014323349,"version":"4.4.0"},"reference-count":321,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijbiomac.2026.154063","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:53:30Z","timestamp":1786722810000},"page":"154063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Allosteric modulation of ionotropic and G protein-coupled receptors in Alzheimer's disease: A neuroprotective strategy and therapeutic implications"],"prefix":"10.1016","volume":"379","author":[{"given":"Ali","family":"Fereidouni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setayesh","family":"Nematollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Thomas","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viane","family":"Favennec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Liceran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Aldenhoff-Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alcocer","family":"Valdivieso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Trent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrollah","family":"Moradikor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.154063_bb0005","author":"WHO, World Health Organization"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0010","author":"Alzheimer's Disease International"},{"issue":"10452","key":"10.1016\/j.ijbiomac.2026.154063_bb0015","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the Lancet commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0020","author":"Lancet Commission portal summary"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154063_bb0030","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-\u03b2 pathway in Alzheimer\u2019s disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106743","article-title":"Discoveries and future significance of research into amyloid-beta\/\u03b17-containing nicotinic acetylcholine receptor (nAChR) interactions","volume":"191","author":"Whiteaker","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0040","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41380-025-03241-4","article-title":"The alpha7 nicotinic acetylcholine receptor mediates network dysfunction in a mouse model of local amyloid pathology","volume":"31","author":"Koukouli","year":"2026","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154063_bb0045","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154063_bb0050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","article-title":"Extrasynaptic NMDA receptor involvement in central nervous system disorders","volume":"82","author":"Parsons","year":"2014","journal-title":"Neuron"},{"issue":"47","key":"10.1016\/j.ijbiomac.2026.154063_bb0055","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.3021-10.2010","article-title":"Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-\u03b2 production","volume":"30","author":"Bordji","year":"2010","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0060","article-title":"Donepezil for dementia due to Alzheimer's disease","volume":"6","author":"Birks","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001191.pub3","article-title":"Rivastigmine for Alzheimer\u2019s disease","volume":"9","author":"Birks","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154063_bb0075","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s40266-023-01065-x","article-title":"Psychiatric adverse events of acetylcholinesterase inhibitors in Alzheimer\u2019s disease and Parkinson\u2019s dementia: systematic review and meta-analysis","volume":"40","author":"Bittner","year":"2023","journal-title":"Drugs Aging"},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.154063_bb0080","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer\u2019s disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0085","article-title":"Memantine for dementia","volume":"3","author":"McShane","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0090","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ibra.12098","article-title":"Basic information about memantine and its treatment of Alzheimer's disease and other clinical applications","volume":"9","author":"Tang","year":"2023","journal-title":"Ibrain"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0100","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2760","article-title":"Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders","volume":"8","author":"Conn","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"32","key":"10.1016\/j.ijbiomac.2026.154063_bb0110","doi-asserted-by":"crossref","first-page":"19478","DOI":"10.1074\/jbc.R115.662759","article-title":"Novel allosteric modulators of G protein-coupled receptors","volume":"290","author":"Gentry","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuropharm.2010.07.010","article-title":"Allosteric modulation of G protein-coupled receptors: a pharmacological perspective","volume":"60","author":"Keov","year":"2011","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb0120","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1471-4892(03)00107-3","article-title":"Allosteric modulators of G-protein-coupled receptors","volume":"3","author":"May","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb0125","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.cell.2016.08.015","article-title":"Allosteric modulation as a unifying mechanism for receptor function and regulation","volume":"166","author":"Changeux","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114013","article-title":"Probe dependence and biased potentiation of metabotropic glutamate receptor 5 is mediated by differential ligand interactions in the common allosteric binding site","volume":"177","author":"Hellyer","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0135","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1074\/jbc.M111.314278","article-title":"A Monod-Wyman-Changeux mechanism can explain G protein-coupled receptor (GPCR) allosteric modulation","volume":"287","author":"Canals","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154063_bb0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cell.2013.03.034","article-title":"Allostery in disease and in drug discovery","volume":"153","author":"Nussinov","year":"2013","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154063_bb0145","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.str.2019.01.003","article-title":"Allostery in its many disguises: from theory to applications","volume":"27","author":"Wodak","year":"2019","journal-title":"Structure"},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.154063_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167751","article-title":"Multiscale allostery: basic mechanisms and versatility in diagnostics and drug design","volume":"434","author":"Berezovsky","year":"2022","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0155","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1124\/jpet.123.001838","article-title":"Allostery: the good, the bad, and the ugly","volume":"388","author":"Kenakin","year":"2024","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev-pharmtox-010611-134525","article-title":"Drugs for allosteric sites on receptors","volume":"54","author":"Wenthur","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0165","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nrd746","article-title":"Allosteric binding sites on cell-surface receptors: novel targets for drug discovery","volume":"1","author":"Christopoulos","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154063_bb0170","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1016\/j.ddtec.2012.10.007","article-title":"Allosteric modulation of class C GPCRs: a novel approach for the treatment of CNS disorders","volume":"10","author":"Engers","year":"2013","journal-title":"Drug Discov. Today Technol."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.154063_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169050","article-title":"Allostery in disease: anticancer drugs, pockets, and the tumor heterogeneity challenge","volume":"437","author":"Nussinov","year":"2025","journal-title":"J. Mol. Biol."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.154063_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169407","article-title":"Allostery in disease: from mutations, mechanisms, and signalling partners to diagnostic and drug therapies","volume":"437","author":"Berezovsky","year":"2025","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102758","article-title":"Allosteric drugs: new principles and design approaches","volume":"84","author":"Tee","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.sbi.2020.01.010","article-title":"Allosteric drugs and mutations: chances, challenges, and necessity","volume":"62","author":"Guarnera","year":"2020","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2025.103172","article-title":"Allosteric solution to the problems of undruggable targets, drug toxicity, and emerging resistance","volume":"95","author":"Tee","year":"2025","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004678","article-title":"Structure-based statistical mechanical model accounts for the causality and energetics of allosteric communication","volume":"12","author":"Guarnera","year":"2016","journal-title":"PLoS Comput. Biol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006228","article-title":"Reversing allosteric communication: from detecting allosteric sites to inducing and tuning targeted allosteric response","volume":"14","author":"Tee","year":"2018","journal-title":"PLoS Comput. Biol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb0210","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.str.2019.01.014","article-title":"Toward comprehensive allosteric control over protein activity","volume":"27","author":"Guarnera","year":"2019","journal-title":"Structure"},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.154063_bb0215","doi-asserted-by":"crossref","DOI":"10.1063\/5.0139848","article-title":"Sequence-dependent model of allosteric communication","volume":"158","author":"Guarnera","year":"2023","journal-title":"J. Chem. Phys."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.154063_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169293","article-title":"Designing structure-specific and switchable allosteric effectors for GPCRs based on the causality and energetics of inherent signaling","volume":"437","author":"Dong","year":"2025","journal-title":"J. Mol. Biol."},{"issue":"W1","key":"10.1016\/j.ijbiomac.2026.154063_bb0225","doi-asserted-by":"crossref","first-page":"W116","DOI":"10.1093\/nar\/gkaa338","article-title":"Allosigma 2: paving the way to designing allosteric effectors and to exploring allosteric effects of mutations","volume":"48","author":"Tan","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.ijbiomac.2026.154063_bb0230","doi-asserted-by":"crossref","first-page":"D265","DOI":"10.1093\/nar\/gky1028","article-title":"AlloMAPS: allosteric mutation analysis and polymorphism of signaling database","volume":"47","author":"Tan","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.ijbiomac.2026.154063_bb0235","doi-asserted-by":"crossref","first-page":"D345","DOI":"10.1093\/nar\/gkac828","article-title":"Allomaps 2: allosteric fingerprints of the AlphaFold and Pfam-trRosetta predicted structures for engineering and design","volume":"51","author":"Tan","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0240","article-title":"G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107574","article-title":"Targeting cryptic allosteric sites of G protein-coupled receptors as a novel strategy for biased drug discovery","volume":"212","author":"Qiao","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25020-9","article-title":"Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design","volume":"12","author":"Lu","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0255","article-title":"Delineating the stepwise millisecond allosteric activation mechanism of the class C GPCR dimer mGlu5","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb0260","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","article-title":"Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer a\u03b2 oligomer bound to cellular prion protein","volume":"79","author":"Um","year":"2013","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0265","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.celrep.2017.06.023","article-title":"Silent allosteric modulation of mGluR5 maintains glutamate signaling while rescuing Alzheimer\u2019s mouse phenotypes","volume":"20","author":"Haas","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0270","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.neuropharm.2017.06.009","article-title":"The AMPA receptor positive allosteric modulator S 47445 rescues in vivo CA3-CA1 long-term potentiation and structural synaptic changes in old mice","volume":"123","author":"Giralt","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0275","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.trci.2019.04.002","article-title":"A 24-week double-blind placebo-controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms","volume":"5","author":"Bernard","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-01215-3","article-title":"Calcium-sensing receptor antagonist NPS 2143 restores amyloid precursor protein physiological non-amyloidogenic processing in A\u03b2-exposed adult human astrocytes","volume":"7","author":"Chiarini","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb0285","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1007\/s12035-023-03699-9","article-title":"P2X7 receptor: an emerging target in Alzheimer\u2019s disease","volume":"61","author":"Huang","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0290","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.neuron.2018.05.018","article-title":"Glutamatergic signaling in the central nervous system: ionotropic and metabotropic receptors in concert","volume":"98","author":"Reiner","year":"2018","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154063_bb0295","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/156720511795256053","article-title":"EHT0202 in Alzheimer\u2019s disease: a 3-month, randomized, placebo-controlled, double-blind study","volume":"8","author":"Vellas","year":"2011","journal-title":"Curr. Alzheimer Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0300","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/mol.116.104240","article-title":"Understanding the bases of function and modulation of \u03b17 nicotinic receptors: implications for drug discovery","volume":"90","author":"Corradi","year":"2016","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0305","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.70061","article-title":"Therapeutic targeting of the \u03b17 nicotinic receptor: challenges and prospects for cognitive improvement in Alzheimer\u2019s and schizophrenia","volume":"137","author":"Magnussen","year":"2025","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0310","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pneurobio.2016.01.002","article-title":"Positive modulators of the \u03b17 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer\u2019s disease","volume":"144","author":"Echeverria","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0315","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuropharm.2016.08.033","article-title":"Positive allosteric modulators of the \u03b17 nicotinic acetylcholine receptor potentiate glutamate release in the prefrontal cortex of freely-moving rats","volume":"111","author":"Bortz","year":"2016","journal-title":"Neuropharmacology"},{"issue":"S1","key":"10.1016\/j.ijbiomac.2026.154063_bb0320","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjp.0706444","article-title":"The glutamate story","volume":"147","author":"Watkins","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0325","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1152\/physrev.00014.2003","article-title":"Long-term potentiation and memory","volume":"84","author":"Lynch","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111310","article-title":"Fear conditioning: insights into learning, memory and extinction and its relevance to clinical disorders","volume":"138","author":"Trent","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154063_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041177","article-title":"Structure-function relationship of transporters in the glutamate-glutamine cycle of the central nervous system","volume":"19","author":"Hayashi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101838","article-title":"Glutamatergic neurotransmission: a potential pharmacotherapeutic target for the treatment of cognitive disorders","volume":"85","author":"Chakraborty","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2024.103039","article-title":"Glutamatergic neurotransmission in aging and neurodegenerative diseases: a potential target to improve cognitive impairment in aging","volume":"55","author":"Castillo-Vazquez","year":"2024","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0350","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.sbi.2019.05.004","article-title":"Structural biology of glutamate receptor ion channels: toward an understanding of mechanism","volume":"57","author":"Greger","year":"2019","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0355","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154063_bb0360","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1124\/pharmrev.120.000131","article-title":"Structure, function, and pharmacology of glutamate receptor ion channels","volume":"73","author":"Hansen","year":"2021","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0365","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.tibs.2015.04.002","article-title":"Emerging structural insights into the function of ionotropic glutamate receptors","volume":"40","author":"Karakas","year":"2015","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0370","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.neuron.2013.10.025","article-title":"AMPARs and synaptic plasticity: the last 25 years","volume":"80","author":"Huganir","year":"2013","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0375","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.conb.2012.01.007","article-title":"Synaptic plasticity of NMDA receptors: mechanisms and functional implications","volume":"22","author":"Hunt","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154063_bb0380","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1038\/s41401-025-01576-w","article-title":"Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases-an update","volume":"46","author":"Wu","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.154063_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207452","article-title":"The dual role of glutamatergic neurotransmission in Alzheimer\u2019s disease: from pathophysiology to pharmacotherapy","volume":"21","author":"Bukke","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.ijbiomac.2026.154063_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29235744","article-title":"Glutamate: molecular mechanisms and signaling pathway in Alzheimer\u2019s disease, a potential therapeutic target","volume":"29","author":"Puranik","year":"2024","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154063_bb0395","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/s41380-024-02473-0","article-title":"The glutamatergic system in Alzheimer\u2019s disease: a systematic review with meta-analysis","volume":"29","author":"Soares","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.154063_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111677","article-title":"Glutamate and GABA in microglia-neuron cross-talk in Alzheimer\u2019s disease","volume":"22","author":"Czapski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7113","key":"10.1016\/j.ijbiomac.2026.154063_bb0405","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nature05289","article-title":"A network dysfunction perspective on neurodegenerative diseases","volume":"443","author":"Palop","year":"2006","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154063_bb0410","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"5896","key":"10.1016\/j.ijbiomac.2026.154063_bb0415","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1126\/science.1162844","article-title":"Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer\u2019s disease","volume":"321","author":"Busche","year":"2008","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154063_bb0420","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn1503","article-title":"Regulation of NMDA receptor trafficking by amyloid-\u03b2","volume":"8","author":"Snyder","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154063_bb0425","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuron.2018.10.018","article-title":"The AMPA receptor code of synaptic plasticity","volume":"100","author":"Diering","year":"2018","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154063_bb0430","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0166-2236(02)02270-1","article-title":"Regulation of AMPA receptors during synaptic plasticity","volume":"25","author":"Song","year":"2002","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154063_bb0435","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuron.2009.02.027","article-title":"Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach","volume":"62","author":"Lu","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0440","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2011.00042","article-title":"Ca2+ permeable AMPA channels in diseases of the nervous system","volume":"4","author":"Weiss","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0445","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neuropharm.2016.08.022","article-title":"Ca2+\u2212permeable AMPA receptor: a new perspective on amyloid-beta mediated pathophysiology of Alzheimer\u2019s disease","volume":"112","author":"Whitehead","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010111","article-title":"Molecular mechanisms of AMPA receptor trafficking in the nervous system","volume":"25","author":"Cao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154063_bb0455","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neuron.2017.04.009","article-title":"Structural and functional architecture of AMPA-type glutamate receptors and their auxiliary proteins","volume":"94","author":"Greger","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174310","article-title":"NMDA and AMPA receptors dysregulation in Alzheimer\u2019s disease","volume":"908","author":"Babaei","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0465","doi-asserted-by":"crossref","DOI":"10.1007\/s10571-024-01529-7","article-title":"AMPA receptors in synaptic plasticity, memory function, and brain diseases","volume":"45","author":"de Le\u00f3n-L\u00f3pez","year":"2025","journal-title":"Cell. Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154063_bb0470","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jnen\/nlae093","article-title":"AMPA receptors in Alzheimer disease: pathological changes and potential therapeutic targets","volume":"83","author":"Ning","year":"2024","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0475","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0959-4388(00)00091-X","article-title":"Hebb and homeostasis in neuronal plasticity","volume":"10","author":"Turrigiano","year":"2000","journal-title":"Curr. Opin. Neurobiol."},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.154063_bb0480","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.257972","article-title":"Phosphorylation of the AMPA receptor subunit GluA1 regulates clathrin-mediated receptor internalization","volume":"134","author":"Sathler","year":"2021","journal-title":"J. Cell Sci."},{"issue":"5321","key":"10.1016\/j.ijbiomac.2026.154063_bb0485","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1126\/science.276.5321.2042","article-title":"Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation","volume":"276","author":"Barria","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/3204519","article-title":"Amyloid-\u03b2-induced dysregulation of AMPA receptor trafficking","volume":"2016","author":"Guntupalli","year":"2016","journal-title":"Neural Plast."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb0495","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1152\/jn.00485.2004","article-title":"Amyloid \u03b2 prevents activation of calcium\/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation","volume":"92","author":"Zhao","year":"2004","journal-title":"J. Neurophysiol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154063_bb0500","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0393-24.2024","article-title":"Amyloid-\u03b2-driven synaptic deficits are mediated by synaptic removal of GluA3-containing AMPA receptors","volume":"45","author":"Reinders","year":"2025","journal-title":"J. Neurosci."},{"issue":"50","key":"10.1016\/j.ijbiomac.2026.154063_bb0505","doi-asserted-by":"crossref","first-page":"E6983","DOI":"10.1073\/pnas.1517045112","article-title":"PSD-95 family MAGUKs are essential for anchoring AMPA and NMDA receptor complexes at the postsynaptic density","volume":"112","author":"Chen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0510","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brainres.2009.07.056","article-title":"Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer\u2019s disease","volume":"1292","author":"Gong","year":"2009","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0515","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.neuron.2007.06.041","article-title":"Postsynaptic positioning of endocytic zones and AMPA receptor cycling by physical coupling of dynamin-3 to Homer","volume":"55","author":"Lu","year":"2007","journal-title":"Neuron"},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.154063_bb0520","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1111\/j.1742-4658.2010.07719.x","article-title":"Progressive accumulation of amyloid- \u03b2 oligomers in Alzheimer\u2019s disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins","volume":"277","author":"Pham","year":"2010","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0525","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-22701-2","article-title":"Whole transcriptome profiling of late-onset Alzheimer\u2019s disease patients provides insights into the molecular changes involved in the disease","volume":"8","author":"Annese","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb0530","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.biopsych.2017.07.023","article-title":"A novel microRNA-124\/PTPN1 signal pathway mediates synaptic and memory deficits in Alzheimer\u2019s disease","volume":"83","author":"Wang","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0535","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2021.711564","article-title":"Calcium permeable-AMPA receptors and excitotoxicity in neurological disorders","volume":"15","author":"Guo","year":"2021","journal-title":"Front. Neural Circuits"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154063_bb0540","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.neurobiolaging.2014.02.018","article-title":"Hippocampus-specific deficiency in RNA editing of GluA2 in Alzheimer\u2019s disease","volume":"35","author":"Gaisler-Salomon","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154063_bb0545","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1261\/rna.054627.115","article-title":"Reduced levels of protein recoding by A-to-I RNA editing in Alzheimer's disease","volume":"22","author":"Khermesh","year":"2016","journal-title":"RNA"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0550","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-020-0545-1","article-title":"A new mouse line with reduced GluA2 Q\/R site RNA editing exhibits loss of dendritic spines, hippocampal CA1-neuron loss, learning and memory impairments and NMDA receptor-independent seizure vulnerability","volume":"13","author":"Konen","year":"2020","journal-title":"Mol. Brain"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0555","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-023-00632-5","article-title":"The Q\/R editing site of AMPA receptor GluA2 subunit acts as an epigenetic switch regulating dendritic spines, neurodegeneration and cognitive deficits in Alzheimer\u2019s disease","volume":"18","author":"Wright","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0560","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","article-title":"Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration","volume":"68","author":"Hoover","year":"2010","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107237","article-title":"Tau regulates Arc stability in neuronal dendrites via a proteasome-sensitive but ubiquitin-independent pathway","volume":"300","author":"Yakout","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0570","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/hmg\/ddr576","article-title":"A critical role for the PAR-1\/MARK-tau axis in mediating the toxic effects of A\u03b2 on synapses and dendritic spines","volume":"21","author":"Yu","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb0575","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0896-6273(00)80632-7","article-title":"NMDA induces long-term synaptic depression and dephosphorylation of the GluR1 subunit of AMPA receptors in hippocampus","volume":"21","author":"Lee","year":"1998","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154063_bb0580","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3233\/JAD-180451","article-title":"Heme oxygenase 1 induces tau oligomer formation and synapse aberrations in hippocampal neurons","volume":"65","author":"Si","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.154063_bb0585","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26136450","article-title":"Positive AMPA and kainate receptor modulators and their therapeutic potential in CNS diseases: a comprehensive review","volume":"26","author":"Vialko","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0590","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuroscience.2008.12.018","article-title":"Ampakines cause sustained increases in brain-derived neurotrophic factor signaling at excitatory synapses without changes in AMPA receptor subunit expression","volume":"159","author":"Lauterborn","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0595","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.coph.2014.11.002","article-title":"AMPA receptor potentiators: from drug design to cognitive enhancement","volume":"20","author":"Partin","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154063_bb0600","first-page":"724","article-title":"CX691 as an AMPA receptor positive modulator, improves the learning and memory in a rat model of Alzheimer\u2019s disease","volume":"21","author":"Mozafari","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"1\u20133","key":"10.1016\/j.ijbiomac.2026.154063_bb0605","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00213-008-1325-2","article-title":"Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat","volume":"202","author":"Woolley","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0610","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00462","article-title":"S 47445 produces antidepressant- and anxiolytic-like effects through neurogenesis dependent and independent mechanisms","volume":"8","author":"Mendez-David","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154063_bb0615","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184429","article-title":"Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptors","volume":"12","author":"Bretin","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154063_bb0620","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1038\/s41380-020-0794-5","article-title":"Allosteric modulation of AMPA receptors counteracts Tau-related excitotoxic synaptic signaling and memory deficits in stress- and A\u03b2-evoked hippocampal pathology","volume":"26","author":"Monteiro-Fernandes","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0625","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/npp.2008.158","article-title":"Targeting AMPA and kainate receptors in neurological disease: therapies on the horizon?","volume":"34","author":"Swanson","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0630","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/cpdd.1475","article-title":"Safety, tolerability, and pharmacokinetic profile of the low-impact ampakine CX1739 in young healthy volunteers","volume":"14","author":"Radin","year":"2025","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154063_bb0635","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/s41594-024-01328-0","article-title":"Allosteric competition and inhibition in AMPA receptors","volume":"31","author":"Hale","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154063_bb0640","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300837R","article-title":"Acute inhibition of AMPA receptors by perampanel reduces amyloid \u03b2-protein levels by suppressing \u03b2-cleavage of APP in Alzheimer\u2019s disease models","volume":"37","author":"Ueda","year":"2023","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154063_bb0645","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41380-022-01459-0","article-title":"Amyloid-\u03b2 oligomers in the nucleus accumbens decrease motivation via insertion of calcium-permeable AMPA receptors","volume":"27","author":"Guo","year":"2022","journal-title":"Mol. Psychiatry."},{"issue":"22","key":"10.1016\/j.ijbiomac.2026.154063_bb0650","doi-asserted-by":"crossref","DOI":"10.3390\/cells11223608","article-title":"\u03b1-Lipoic acid derivatives as allosteric modulators for targeting AMPA-type glutamate receptors' gating modules","volume":"11","author":"Qneibi","year":"2022","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154063_bb0655","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/s41386-018-0033-9","article-title":"M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition","volume":"43","author":"Moran","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0660","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0665","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuroscience.2010.01.022","article-title":"Organization of NMDA receptors at extrasynaptic locations","volume":"167","author":"Petralia","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0670","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnins.2019.00043","article-title":"The role of NMDA receptors in Alzheimer\u2019s disease","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0675","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s12031-020-01747-w","article-title":"Hippocampal degeneration and behavioral impairment during Alzheimer-like pathogenesis involves glutamate excitotoxicity","volume":"71","author":"Olajide","year":"2021","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0680","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-00732-5","article-title":"Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120","volume":"7","author":"Allsopp","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0685","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","article-title":"Synaptic degeneration in Alzheimer disease","volume":"19","author":"Tzioras","year":"2023","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154063_bb0690","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer\u2019s disease, \u03b2-amyloid, glutamate, NMDA receptors and memantine--searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2023.102534","article-title":"The role of N-methyl-D-aspartate glutamate receptors in Alzheimer\u2019s disease: from pathophysiology to therapeutic approaches","volume":"231","author":"Liu","year":"2023","journal-title":"Prog. Neurobiol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154063_bb0700","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1073\/pnas.0811698106","article-title":"Oligomeric amyloid \u03b2 associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques","volume":"106","author":"Koffie","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154063_bb0705","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/brain\/aws127","article-title":"Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-\u03b2","volume":"135","author":"Koffie","year":"2012","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0710","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1471-4159.2010.07058.x","article-title":"N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer\u2019s toxic amyloid-\u03b2 peptide oligomers","volume":"115","author":"Decker","year":"2010","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0715","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","article-title":"Soluble oligomers of amyloid \u03b2 protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake","volume":"62","author":"Li","year":"2009","journal-title":"Neuron"},{"issue":"44","key":"10.1016\/j.ijbiomac.2026.154063_bb0720","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.1523\/JNEUROSCI.3478-07.2007","article-title":"\u03b2-Amyloid modulation of synaptic transmission and plasticity","volume":"27","author":"Venkitaramani","year":"2007","journal-title":"J. Neurosci."},{"issue":"6453","key":"10.1016\/j.ijbiomac.2026.154063_bb0725","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1126\/science.aay0198","article-title":"A vicious cycle of \u03b2 amyloid-dependent neuronal hyperactivation","volume":"365","author":"Zott","year":"2019","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0730","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.140","article-title":"Overexpression of EphB2 in hippocampus rescues impaired NMDA receptors trafficking and cognitive dysfunction in Alzheimer model","volume":"8","author":"Hu","year":"2017","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0735","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ceca.2009.12.010","article-title":"Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors","volume":"47","author":"Alberdi","year":"2010","journal-title":"Cell Calcium"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0740","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ceca.2011.02.001","article-title":"Amyloid \u03b2 peptide oligomers directly activate NMDA receptors","volume":"49","author":"Texid\u00f3","year":"2011","journal-title":"Cell Calcium"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0745","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-04687-y","article-title":"Amyloid \u03b2\/PKC-dependent alterations in NMDA receptor composition are detected in early stages of Alzheimer\u2019s disease","volume":"13","author":"Ortiz-Sanz","year":"2022","journal-title":"Cell Death Dis."},{"issue":"31","key":"10.1016\/j.ijbiomac.2026.154063_bb0750","doi-asserted-by":"crossref","first-page":"11328","DOI":"10.1523\/JNEUROSCI.0607-11.2011","article-title":"Opposing synaptic regulation of amyloid-\u03b2 metabolism by NMDA receptors in vivo","volume":"31","author":"Verges","year":"2011","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154063_bb0755","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022112453","article-title":"Jacob-induced transcriptional inactivation of CREB promotes A\u03b2-induced synapse loss in Alzheimer\u2019s disease","volume":"42","author":"Grochowska","year":"2023","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb0760","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154063_bb0765","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1523\/JNEUROSCI.2842-14.2015","article-title":"Tau phosphorylation at serine 396 residue is required for hippocampal LTD","volume":"35","author":"Regan","year":"2015","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154063_bb0770","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.329","article-title":"Extrasynaptic NMDA receptor-induced tau overexpression mediates neuronal death through suppressing survival signaling ERK phosphorylation","volume":"7","author":"Sun","year":"2016","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154063_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109638","article-title":"Long-term depression links amyloid-\u03b2 to the pathological hyperphosphorylation of tau","volume":"36","author":"Taylor","year":"2021","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0780","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-\u03b2 toxicity in Alzheimer\u2019s disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154063_bb0785","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24109067","article-title":"Role of calcium modulation in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"24","author":"Baracaldo-Santamar\u00eda","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154063_bb0790","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094914","article-title":"Calcium dyshomeostasis in Alzheimer\u2019s disease pathogenesis","volume":"22","author":"Cascella","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"37","key":"10.1016\/j.ijbiomac.2026.154063_bb0795","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0675-24.2024","article-title":"Amyloid-\u03b2 causes NMDA receptor dysfunction and dendritic spine loss through mGluR1 and AKAP150-anchored calcineurin signaling","volume":"44","author":"Prikhodko","year":"2024","journal-title":"J. Neurosci."},{"issue":"22","key":"10.1016\/j.ijbiomac.2026.154063_bb0800","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213954","article-title":"Alzheimer\u2019s disease: treatment strategies and their limitations","volume":"23","author":"Passeri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102775","article-title":"Advances in Alzheimer\u2019s therapy: exploring neuropathological mechanisms to revolutionize the future therapeutic landscape","volume":"109","author":"Sugandhi","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154063_bb0810","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043841","article-title":"Neurotransmitters in prevention and treatment of Alzheimer\u2019s disease","volume":"24","author":"Yang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0815","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist-a review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0820","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1471-4159.2006.03991.x","article-title":"The chemical biology of clinically tolerated NMDA receptor antagonists","volume":"97","author":"Chen","year":"2006","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0825","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/s41380-025-03288-3","article-title":"Alzheimer\u2019s disease and memantine effects on NMDA-receptor blockade: non-invasive in vivo insights from magnetoencephalography","volume":"31","author":"Lanskey","year":"2026","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb0830","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-170672","article-title":"Memantine for the treatment of dementia: a review on its current and future applications","volume":"62","author":"Folch","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"33","key":"10.1016\/j.ijbiomac.2026.154063_bb0835","doi-asserted-by":"crossref","first-page":"11246","DOI":"10.1523\/JNEUROSCI.2488-10.2010","article-title":"Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses","volume":"30","author":"Xia","year":"2010","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154063_bb0840","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.1002\/alz.14125","article-title":"Synaptic and extrasynaptic distribution of NMDA receptors in the cortex of Alzheimer\u2019s disease patients","volume":"20","author":"Escamilla","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0845","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s12264-013-1383-2","article-title":"Dysregulation of synaptic and extrasynaptic N-methyl-D-aspartate receptors induced by amyloid-\u03b2","volume":"29","author":"Wang","year":"2013","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109737","article-title":"Memantine: updating a rare success story in pro-cognitive therapeutics","volume":"244","author":"Karimi Tari","year":"2024","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0855","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb0860","doi-asserted-by":"crossref","first-page":"962","DOI":"10.15252\/embr.201643519","article-title":"Posttranslational modification impact on the mechanism by which amyloid-\u03b2 induces synaptic dysfunction","volume":"18","author":"Grochowska","year":"2017","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0865","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pharmthera.2016.04.010","article-title":"Pharmacology of dextromethorphan: relevance to dextromethorphan\/quinidine (Nuedexta\u00ae) clinical use","volume":"164","author":"Taylor","year":"2016","journal-title":"Pharmacol. Ther."},{"issue":"6513","key":"10.1016\/j.ijbiomac.2026.154063_bb0870","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay3302","article-title":"Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectants","volume":"370","author":"Yan","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154063_bb0875","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41380-025-03143-5","article-title":"The NMDAR\/TRPM4 death complex is a major promoter of disease progression in the 5xFAD mouse model of Alzheimer\u2019s disease","volume":"31","author":"Yan","year":"2026","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154063_bb0880","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11011-025-01538-5","article-title":"Brain interleukins and Alzheimer\u2019s disease","volume":"40","author":"Abdelhamed","year":"2025","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0885","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-8-14","article-title":"Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1\u03b2 and NMDA stimulation","volume":"8","author":"Gardoni","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0890","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1196413","article-title":"Alzheimer\u2019s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?","volume":"14","author":"Melchiorri","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154063_bb0895","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1831","article-title":"Memantine, donepezil, or combination therapy-what is the best therapy for Alzheimer\u2019s disease? A network meta-analysis","volume":"10","author":"Guo","year":"2020","journal-title":"Brain Behav."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0900","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41386-023-01614-3","article-title":"Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry","volume":"49","author":"Hanson","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0905","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2016.00031","article-title":"Implications of GABAergic neurotransmission in Alzheimer\u2019s disease","volume":"8","author":"Li","year":"2016","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb0910","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/jnc.14325","article-title":"GABA(A) receptor subunit expression changes in the human Alzheimer\u2019s disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus","volume":"145","author":"Kwakowsky","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119533","article-title":"Bumetanide as a potential treatment for neurodegenerative and neurodevelopmental disorders: a systematic review","volume":"200","author":"McNamara","year":"2026","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154063_bb0920","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1038\/s41380-025-03217-4","article-title":"Hyperactivity of subicular parvalbumin interneurons drives early amyloid pathology and cognitive deficits in Alzheimer\u2019s disease","volume":"30","author":"Chen","year":"2025","journal-title":"Mol. Psychiatry."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0925","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2024.12.001","article-title":"Procognitive and neurotrophic benefits of \u03b15-GABA-A receptor positive allosteric modulation in a \u03b2-amyloid deposition mouse model of Alzheimer\u2019s disease pathology","volume":"147","author":"Bernardo","year":"2025","journal-title":"Neurobiol. Aging"},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.154063_bb0930","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1073\/pnas.1001422107","article-title":"Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer\u2019s disease","volume":"107","author":"Wang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2024.102928","article-title":"Targeting calciumopathy for neuroprotection: focus on calcium channels Cav1, Orai1 and P2X7","volume":"123","author":"Torres-Rico","year":"2024","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0940","article-title":"P2X7 receptor inhibition ameliorates ubiquitin-proteasome system dysfunction associated with Alzheimer\u2019s disease","volume":"15","author":"Bianchi","year":"2023","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0945","first-page":"183","article-title":"Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer\u2019s disease and schizophrenia","volume":"10","author":"Foster","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154063_bb0950","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.3390\/cimb46070407","article-title":"Muscarinic receptors and Alzheimer\u2019s disease: new perspectives and mechanisms","volume":"46","author":"Monaco","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb0955","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pharmthera.2008.04.006","article-title":"Synthesis, trafficking, and localization of muscarinic acetylcholine receptors","volume":"119","author":"Nathanson","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0960","series-title":"Pharmacology and Therapeutics","first-page":"91","article-title":"Chapter 8 - neurotransmitters","author":"Benarroch","year":"2009"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108786","article-title":"Biased signaling in GPCRs: structural insights and implications for drug development","volume":"266","author":"Ma","year":"2025","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154063_bb0970","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1523\/JNEUROSCI.6393-09.2010","article-title":"Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo","volume":"30","author":"Davis","year":"2010","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154063_bb0975","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1074\/jbc.270.9.4916","article-title":"Muscarinic regulation of Alzheimer\u2019s disease amyloid precursor protein secretion and amyloid \u03b2-protein production in human neuronal NT2N cells (\u2217)","volume":"270","author":"Wolf","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154063_bb0980","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3233\/JAD-150152","article-title":"Acute effects of muscarinic M1 receptor modulation on A\u03b2PP metabolism and amyloid-\u03b2 levels in vivo: a microdialysis study","volume":"46","author":"Welt","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154063_bb0985","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1046\/j.1471-4159.1996.66020877.x","article-title":"Activation of m1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells","volume":"66","author":"Sadot","year":"1996","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb0990","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neuron.2006.01.020","article-title":"M1 receptors play a central role in modulating AD-like pathology in transgenic mice","volume":"49","author":"Caccamo","year":"2006","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154063_bb0995","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/npp.2013.70","article-title":"Blockade of tau hyperphosphorylation and A\u03b21-42 generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and \u03c31 receptor agonist, in a nontransgenic mouse model of Alzheimer\u2019s disease","volume":"38","author":"Lahmy","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1000","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuropharm.2018.09.020","article-title":"Muscarinic receptor antagonists activate ERK-CREB signaling to augment neurite outgrowth of adult sensory neurons","volume":"143","author":"Sabbir","year":"2018","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154063_bb1005","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.neurobiolaging.2006.06.001","article-title":"Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer\u2019s disease","volume":"28","author":"Tsang","year":"2007","journal-title":"Neurobiol. Aging"},{"issue":"24","key":"10.1016\/j.ijbiomac.2026.154063_bb1010","doi-asserted-by":"crossref","first-page":"13311","DOI":"10.1073\/pnas.94.24.13311","article-title":"Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice","volume":"94","author":"Hamilton","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154063_bb1015","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1021\/acsmedchemlett.8b00095","article-title":"MK-7622: a first-in-class M(1) positive allosteric modulator development candidate","volume":"9","author":"Beshore","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154063_bb1020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archneur.1997.00550160091022","article-title":"Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease","volume":"54","author":"Bodick","year":"1997","journal-title":"Arch. Neurol."},{"issue":"37","key":"10.1016\/j.ijbiomac.2026.154063_bb1025","doi-asserted-by":"crossref","first-page":"15950","DOI":"10.1073\/pnas.0900903106","article-title":"Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation","volume":"106","author":"Ma","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154063_bb1030","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1074\/jbc.M113.539080","article-title":"Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor","volume":"289","author":"Abdul-Ridha","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbr.2015.03.029","article-title":"The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer\u2019s disease mouse model","volume":"287","author":"Puri","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154063_bb1040","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1021\/acschemneuro.8b00131","article-title":"A novel M(1) PAM VU0486846 exerts efficacy in cognition models without displaying agonist activity or cholinergic toxicity","volume":"9","author":"Rook","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116388","article-title":"A M1 muscarinic acetylcholine receptor-specific positive allosteric modulator VU0486846 reduces neurogliosis in female Alzheimer\u2019s mice","volume":"173","author":"Abd-Elrahman","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.trci.2018.03.004","article-title":"Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer's disease","volume":"4","author":"Voss","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1055","doi-asserted-by":"crossref","DOI":"10.1042\/NS20210004","article-title":"Targeting the M1 muscarinic acetylcholine receptor in Alzheimer\u2019s disease","volume":"6","author":"Dwomoh","year":"2022","journal-title":"Neuron. Signal."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0165-6147(93)90107-U","article-title":"Metabotropic glutamate receptors in brain function and pathology","volume":"14","author":"Schoepp","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2012.00182","article-title":"Group 1 metabotropic glutamate receptor function and its regulation of learning and memory in the aging brain","volume":"3","author":"M\u00e9nard","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2026.154063_bb1075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(02)00272-3","article-title":"Glutamate receptor function in learning and memory","volume":"140","author":"Riedel","year":"2003","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154063_bb1080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrd1630","article-title":"Metabotropic glutamate receptors as novel targets for anxiety and stress disorders","volume":"4","author":"Swanson","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1085","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108275","article-title":"Targeting mGluR2\/3 for treatment of neurodegenerative and neuropsychiatric diseases","volume":"239","author":"Li","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154063_bb1090","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3233\/JAD-201146","article-title":"Metabotropic glutamate receptors in Alzheimer\u2019s disease synaptic dysfunction: therapeutic opportunities and hope for the future","volume":"78","author":"Srivastava","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1095","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2012.00199","article-title":"Translational concepts of mGluR5 in synaptic diseases of the brain","volume":"3","author":"Piers","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"Pt 2","key":"10.1016\/j.ijbiomac.2026.154063_bb1100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1469-7793.2001.00421.x","article-title":"A characterisation of long-term depression induced by metabotropic glutamate receptor activation in the rat hippocampus in vitro","volume":"537","author":"Fitzjohn","year":"2001","journal-title":"J. Physiol."},{"issue":"28","key":"10.1016\/j.ijbiomac.2026.154063_bb1105","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1523\/JNEUROSCI.0995-04.2004","article-title":"Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression","volume":"24","author":"Hou","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-pharmtox-021821-091747","article-title":"Noncanonical metabotropic glutamate receptor 5 signaling in Alzheimer\u2019s disease","volume":"62","author":"Abd-Elrahman","year":"2022","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb1115","first-page":"147","article-title":"Regulation and function of activity-dependent Homer in synaptic plasticity","volume":"5","author":"Clifton","year":"2019","journal-title":"Mol. Neuropsychiatry"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb1120","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(00)80810-7","article-title":"Coupling of mGluR\/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins","volume":"23","author":"Tu","year":"1999","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154063_bb1125","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.celrep.2016.04.077","article-title":"Chronic pharmacological mGluR5 inhibition prevents cognitive impairment and reduces pathogenesis in an alzheimer disease mouse model","volume":"15","author":"Hamilton","year":"2016","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1130","doi-asserted-by":"crossref","DOI":"10.1186\/1756-6606-7-40","article-title":"Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer\u2019s disease","volume":"7","author":"Hamilton","year":"2014","journal-title":"Mol. Brain"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb1135","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neuron.2010.04.029","article-title":"Deleterious effects of amyloid \u03b2 oligomers acting as an extracellular scaffold for mGluR5","volume":"66","author":"Renner","year":"2010","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1140","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1503\/jpn.110190","article-title":"Glutamate system, amyloid \u03b2 peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology","volume":"38","author":"Revett","year":"2013","journal-title":"J. Psychiatry Neurosci."},{"issue":"Pt A","key":"10.1016\/j.ijbiomac.2026.154063_bb1145","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuropharm.2016.10.009","article-title":"Brain mGluR5 in mice with amyloid beta pathology studied with in vivo [(11)C]ABP688 PET imaging and ex vivo immunoblotting","volume":"113","author":"Fang","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13195-020-0582-0","article-title":"PET imaging of mGluR5 in Alzheimer\u2019s disease","volume":"12","author":"Mecca","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"7233","key":"10.1016\/j.ijbiomac.2026.154063_bb1155","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-\u03b2 oligomers","volume":"457","author":"Laur\u00e9n","year":"2009","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154063_bb1160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024293","article-title":"Allopregnanolone promotes regeneration and reduces \u03b2-amyloid burden in a preclinical model of Alzheimer\u2019s disease","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb1165","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2990.2010.01103.x","article-title":"Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy","volume":"36","author":"Bhaskar","year":"2010","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1170","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-015-0111-4","article-title":"Ca2+\/Calmodulin-dependent protein kinase II interacts with group I metabotropic glutamate and facilitates receptor endocytosis and ERK1\/2 signaling: role of \u03b2-Amyloid","volume":"8","author":"Raka","year":"2015","journal-title":"Mol. Brain"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuropharm.2010.07.007","article-title":"Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential","volume":"60","author":"Gregory","year":"2011","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb1180","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1124\/mol.112.080531","article-title":"Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships","volume":"82","author":"Gregory","year":"2012","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1185","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-018-0364-9","article-title":"Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer\u2019s disease mouse models","volume":"11","author":"Abd-Elrahman","year":"2018","journal-title":"Mol. Brain"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1190","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.893422","article-title":"Targeting the type 5 metabotropic glutamate receptor: a potential therapeutic strategy for neurodegenerative diseases?","volume":"13","author":"Budgett","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1195","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107785","article-title":"A positive allosteric modulator of mGluR5 promotes neuroprotective effects in mouse models of Alzheimer's disease","volume":"160","author":"Bellozi","year":"2019","journal-title":"Neuropharmacology"},{"issue":"647","key":"10.1016\/j.ijbiomac.2026.154063_bb1200","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abi8593","article-title":"Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q","volume":"14","author":"Spurrier","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb1205","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1632","article-title":"Reduced uptake of [11C]-ABP688, a PET tracer for metabolic glutamate receptor 5 in hippocampus and amygdala in Alzheimer\u2019s dementia","volume":"10","author":"Treyer","year":"2020","journal-title":"Brain Behav."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb1210","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1124\/pr.119.018531","article-title":"International union of basic and clinical pharmacology. CVIII. Calcium-sensing receptor nomenclature, pharmacology, and function","volume":"72","author":"Leach","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1215","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.13662","article-title":"Structural mechanism of ligand activation in human calcium-sensing receptor","volume":"5","author":"Geng","year":"2016","journal-title":"Elife"},{"issue":"46","key":"10.1016\/j.ijbiomac.2026.154063_bb1220","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.4134-08.2008","article-title":"Calcium-sensing receptor activation depresses synaptic transmission","volume":"28","author":"Phillips","year":"2008","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008563","article-title":"Presynaptic external calcium signaling involves the calcium-sensing receptor in neocortical nerve terminals","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1230","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2017.00217","article-title":"Amyloid \u03b2-exposed human astrocytes overproduce phospho-tau and overrelease it within exosomes, effects suppressed by calcilytic NPS 2143-further implications for Alzheimer\u2019s therapy","volume":"11","author":"Chiarini","year":"2017","journal-title":"Front. Neurosci."},{"issue":"33","key":"10.1016\/j.ijbiomac.2026.154063_bb1235","first-page":"4990","article-title":"Targeting human astrocytes\u2019 calcium-sensing receptors for treatment of Alzheimer\u2019s disease","volume":"23","author":"Chiarini","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1240","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1245","article-title":"Increased calcium-sensing receptor immunoreactivity in the hippocampus of a triple transgenic mouse model of Alzheimer\u2019s disease","volume":"11 - 2017","author":"Gardenal","year":"2017","journal-title":"Front. Neurosci."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154063_bb1250","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.bbadis.2013.04.020","volume":"1832","author":"Armato","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154063_bb1255","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s12017-014-8315-9","article-title":"The A\u03b2 peptides-activated calcium-sensing receptor stimulates the production and secretion of vascular endothelial growth factor-A by normoxic adult human cortical astrocytes","volume":"16","author":"Dal Pr\u00e0","year":"2014","journal-title":"Neuromolecular Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154063_bb1260","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061386","article-title":"CaSR antagonist (calcilytic) NPS 2143 hinders the release of neuroinflammatory IL-6, soluble ICAM-1, RANTES, and MCP-2 from A\u03b2-exposed human cortical astrocytes","volume":"9","author":"Chiarini","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1265","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2016.00134","article-title":"Calcium-sensing receptors of human neural cells play crucial roles in Alzheimer\u2019s disease","volume":"7","author":"Chiarini","year":"2016","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154063_bb1270","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ceca.2011.11.009","article-title":"Biased agonism of the calcium-sensing receptor","volume":"51","author":"Thomsen","year":"2012","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1275","article-title":"Calcium-sensing receptor mediates \u03b2-amyloid-induced synaptic formation impairment and cognitive deficits via regulation of cytosolic phospholipase A2\/prostaglandin E2 metabolic pathway","volume":"12 - 2020","author":"Feng","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1280","author":"ClinicalTrials.gov"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1285","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41574-018-0115-0","article-title":"The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases","volume":"15","author":"Hannan","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"51","key":"10.1016\/j.ijbiomac.2026.154063_bb1290","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2115849118","article-title":"Symmetric activation and modulation of the human calcium-sensing receptor","volume":"118","author":"Park","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1295","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13023-017-0570-z","article-title":"Diseases associated with calcium-sensing receptor","volume":"12","author":"Vahe","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb1300","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3233\/JAD-190602","article-title":"Calcilytic NPS 2143 reduces amyloid secretion and increases sA\u03b2PP\u03b1 release from PSEN1 mutant iPSC-derived neurons","volume":"72","author":"Lo Giudice","year":"2019","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1305","series-title":"Cinacalcet Viatris (previously Cinacalcet Mylan)","year":"2017"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154063_bb1310","doi-asserted-by":"crossref","first-page":"E2207","DOI":"10.1210\/jc.2013-4009","article-title":"A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis","volume":"99","author":"Halse","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154063_bb1315","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092344","article-title":"A2A adenosine receptor as a potential biomarker and a possible therapeutic target in Alzheimer\u2019s disease","volume":"10","author":"Gessi","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154063_bb1320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095056","article-title":"A2A adenosine receptor: a possible therapeutic target for Alzheimer\u2019s disease by regulating NLRP3 inflammasome activity?","volume":"23","author":"Merighi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1325","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107726","article-title":"JWX-A0108, a positive allosteric modulator of \u03b17 nAChR, attenuates cognitive deficits in APP\/PS1 mice by suppressing NF-\u03baB-mediated inflammation","volume":"96","author":"Li","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154063_bb1330","doi-asserted-by":"crossref","DOI":"10.1111\/acel.70235","article-title":"Alpha-ketoglutarate ameliorates synaptic plasticity deficits in APP\/PS1 mice model of Alzheimer\u2019s disease","volume":"24","author":"Navakkode","year":"2025","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb1335","doi-asserted-by":"crossref","DOI":"10.3390\/biom12030363","article-title":"Novel therapeutic target for prevention of neurodegenerative diseases: modulation of neuroinflammation with Sig-1R ligands","volume":"12","author":"Bog\u00e1r","year":"2022","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154063_bb1340","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.3390\/ph18121900","article-title":"Pridopidine, a potent and selective therapeutic Sigma-1 Receptor (S1R) agonist for treating neurodegenerative diseases","volume":"18","author":"Gershoni Emek","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154063_bb1345","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081871","article-title":"Identification of novel positive allosteric modulators of neurotrophin receptors for the treatment of cognitive dysfunction","volume":"10","author":"Dahlstr\u00f6m","year":"2021","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154063_bb1350","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3390\/ph17080997","article-title":"Positive allosteric modulators of Trk receptors for the treatment of Alzheimer's disease","volume":"17","author":"Forsell","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1355","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107395","article-title":"GPCR-mediated natural products and compounds: potential therapeutic targets for the treatment of neurological diseases","volume":"208","author":"Wang","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb1360","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3507","article-title":"A comprehensive assessment of the cholinergic-supporting and cognitive-enhancing effects of Rosa damascena Mill. (Damask rose) essential oil on scopolamine-induced amnestic rats","volume":"14","author":"Teral\u0131","year":"2024","journal-title":"Brain Behav."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1365","article-title":"Activation of TGR5 ameliorates streptozotocin-induced cognitive impairment by modulating apoptosis, neurogenesis, and neuronal firing","volume":"1","author":"Mu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1370","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2025.102583","article-title":"Neuropeptide Y at the crossroads of neurodegeneration: mechanistic insights and emerging therapeutic strategies","volume":"115","author":"Palanivel","year":"2026","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1375","article-title":"Pyrazole-derived TRPC3 antagonist ameliorates synaptic dysfunctions and memory deficits in Alzheimer\u2019s disease models","author":"Wang","year":"2026","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1380","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2025.103072","article-title":"Dantrolene normalizes heightened Ca2+ influx in activated T cells from the familial Alzheimer's disease TgF344-AD rats","volume":"132","author":"Uppal","year":"2025","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1385","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110077","article-title":"Riluzole ameliorates soluble A\u03b21-42-induced impairments in spatial memory by modulating the glutamatergic\/GABAergic balance in the dentate gyrus","volume":"108","author":"Yang","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1390","article-title":"Bidirectional crosstalk between microglia and serotonin signaling in neuroinflammation and CNS disorders","volume":"16","author":"Zheng","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1395","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3858\/emm.2008.40.1.11","article-title":"Activation of nicotinic acetylcholine receptor prevents the production of reactive oxygen species in fibrillar \u03b2 amyloid peptide (1-42)-stimulated microglia","volume":"40","author":"Moon","year":"2008","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1400","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115450","article-title":"CCR5 as a key modulator in neurocognitive disorders","volume":"394","author":"Aung","year":"2025","journal-title":"Exp. Neurol."},{"issue":"Pt 2","key":"10.1016\/j.ijbiomac.2026.154063_bb1405","article-title":"G-protein coupled receptors in neuroinflammation, neuropharmacology, and therapeutics","volume":"242","author":"Singh","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154063_bb1410","doi-asserted-by":"crossref","DOI":"10.3390\/ph17070831","article-title":"Targeting microglia in neuroinflammation: H3 receptor antagonists as a novel therapeutic approach for Alzheimer\u2019s disease, Parkinson\u2019s disease, and Autism spectrum disorder","volume":"17","author":"Thomas","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1415","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbi.2023.02.023","article-title":"Real-time mechanisms of exacerbated synaptic remodeling by microglia in acute models of systemic inflammation and tauopathy","volume":"110","author":"Cangalaya","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154063_bb1420","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102642","article-title":"Amyloid beta and its naturally occurring N-terminal variants are potent activators of human and mouse formyl peptide receptor 1","volume":"298","author":"Busch","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104713","article-title":"The S1P receptor 1 antagonist Ponesimod reduces TLR4-induced neuroinflammation and increases A\u03b2 clearance in 5XFAD mice","volume":"94","author":"Zhu","year":"2023","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154063_bb1430","first-page":"5236","article-title":"Somatostatinergic and dopaminergic systems in Alzheimer\u2019s disease: Mechanistic insights and therapeutic opportunities beyond plaques and tangles","volume":"21","author":"Singh","year":"2026","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1435","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.107054","article-title":"Nutrient sensing receptor GPRC6A regulates mTORC1 signaling and Tau biology","volume":"216","author":"Ma","year":"2025","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1440","article-title":"Optimized 5-HT2b inhibitors for neuropsychiatric syndromes with cognitive dysfunction","volume":"11","author":"Roy","year":"2025","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.154063_bb1445","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158185","article-title":"Indomethacin disrupts the formation of \u03b2-amyloid plaques via an \u03b12-macroglobulin-activating lrp1-dependent mechanism","volume":"22","author":"Guan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154063_bb1450","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.71131","article-title":"The GPCR connection: linking Alzheimer\u2019s disease and glioblastoma","volume":"30","author":"Caniceiro","year":"2026","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1455","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2024.137664","article-title":"Altered neuronal group 1 metabotropic glutamate receptor- and endoplasmic reticulum-mediated Ca2+ signaling in two rodent models of Alzheimer\u2019s disease","volume":"823","author":"Kaar","year":"2024","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb1460","doi-asserted-by":"crossref","DOI":"10.3390\/ph18030369","article-title":"A new era of muscarinic acetylcholine receptor modulators in neurological diseases, cancer and drug abuse","volume":"18","author":"Tsimpili","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1465","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-025-02023-x","article-title":"Mitochondrial dysfunction mediated by ER-calcium dysregulation in neurons derived from Alzheimer\u2019s disease patients","volume":"13","author":"Mustaly-Kalimi","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154063_bb1470","article-title":"Antioxioxidant and antiapoptotic effects of Thymosin \u03b24 in A\u03b2-induced SH-SY5Y cells via the 5-HTR1A\/ERK axis","volume":"18","author":"Zhang","year":"2023","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154063_bb1475","doi-asserted-by":"crossref","DOI":"10.3390\/ph18040476","article-title":"Further in vitro and ex vivo pharmacological and kinetic characterizations of CCF219B: a positive allosteric modulator of the \u03b11A-adrenergic receptor","volume":"18","author":"Papay","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1480","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-021-00036-1","article-title":"G-protein coupled receptor, PI3K and Rho signaling pathways regulate the cascades of Tau and amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"2","author":"Desale","year":"2021","journal-title":"Mol. Biomed."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.154063_bb1485","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25168630","article-title":"A comprehensive exploration of the multifaceted neuroprotective role of cannabinoids in Alzheimer\u2019s disease across a decade of research","volume":"25","author":"Tyrakis","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154063_bb1490","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3390\/ph18101425","article-title":"\u03b11A-Adrenergic receptor as a target for neurocognition: cautionary tale from nicergoline and quinazoline non-selective blockers","volume":"18","author":"Perez","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154063_bb1495","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41401-025-01671-y","article-title":"The mGluR2\/3 agonist xanthurenic acid improves memory, attention, and synaptic deficits by modulating glutamate release in Alzheimer\u2019s disease model","volume":"47","author":"Choe","year":"2026","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1500","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12168","article-title":"\u03ba-Opioid receptor agonist, U50488H, inhibits pyroptosis through NLRP3 via the Ca2+\/CaMKII\/CREB signaling pathway and improves synaptic plasticity in APP\/PS1 mice","volume":"24","author":"Song","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb1505","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70163","article-title":"GABAB receptor: structure, biological functions, and therapy for diseases","volume":"6","author":"Xie","year":"2025","journal-title":"MedComm"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154063_bb1510","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102532","article-title":"The CX3CL1 intracellular domain exhibits neuroprotection via insulin receptor\/insulin-like growth factor receptor signaling","volume":"298","author":"Gayen","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.154063_bb1515","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1111\/bph.16389","article-title":"ERNEST COST action overview on the (patho)physiology of GPCRs and orphan GPCRs in the nervous system","volume":"182","author":"Birg\u00fcl Iyison","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1520","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117868","article-title":"Design, synthesis and pharmacological evaluation of multitarget GPR40 agonists\/HDAC6 inhibitors for Alzheimer\u2019s disease","volume":"296","author":"Pinheiro","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb1525","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500922","article-title":"Modulation of Tau protein neurotoxic hallmarks by novel \u03c31 R agonists\/HDAC inhibitor dual-acting compounds","volume":"21","author":"Fallica","year":"2026","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1530","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2025.174085","article-title":"Allosteric modulation of M1 or M4 muscarinic receptors restores eNOS expression and L-arginine metabolism in dementia models and synergizes with NO releasers","volume":"256","author":"P\u0142oska","year":"2025","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154063_bb1535","doi-asserted-by":"crossref","DOI":"10.3390\/biom16020236","article-title":"Galanin receptors: G protein-dependent signaling and beyond","volume":"16","author":"Ol\u00e1h","year":"2026","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1540","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbi.2023.10.021","article-title":"GV1001 modulates neuroinflammation and improves memory and behavior through the activation of gonadotropin-releasing hormone receptors in a triple transgenic Alzheimer\u2019s disease mouse model","volume":"115","author":"Park","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154063_bb1545","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00616","article-title":"Neuroprotective effects of G9a inhibition and cannabinoid receptor activation in Alzheimer's disease through a pharmacological approach","volume":"22","author":"Bellver-Sanchis","year":"2025","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1550","first-page":"53","article-title":"Evaluating neurosurgical interventions versus pharmacotherapy in treating Alzheimer\u2019s disease: a comprehensive review","volume":"2","author":"Moselmani","year":"2024","journal-title":"Neurosci. Updates"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1555","series-title":"Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]","article-title":"Meta-analysis of six-month memantine trials in Alzheimer's disease","author":"Doody","year":"2007"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154063_bb1560","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3233\/JAD-150978","article-title":"Efficacy and safety of ABT-126 in subjects with mild-to-moderate Alzheimer\u2019s disease on stable doses of acetylcholinesterase inhibitors: a randomized, double-blind, placebo-controlled study","volume":"51","author":"Florian","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154063_bb1565","doi-asserted-by":"crossref","first-page":"543","DOI":"10.18632\/aging.102640","article-title":"Activation of \u03b17 nAChR by PNU-282987 improves synaptic and cognitive functions through restoring the expression of synaptic-associated proteins and the CaM-CaMKII-CREB signaling pathway","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1570","article-title":"Activation of \u03b17 nicotinic acetylcholine receptor by its selective agonist improved learning and memory of APP\/PS1 mice via the Nrf2\/HO-1 pathway","volume":"28","author":"Cao","year":"2022","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ijbiomac.2026.154063_bb1575","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110654","article-title":"Positive allosteric modulation of M1 mAChRs with VU0486846 reverses cognitive deficits in male APPswe\/PSEN1\u0394E9 Alzheimer\u2019s mice","volume":"280","author":"Ibrahim","year":"2025","journal-title":"Neuropharmacology"},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.154063_bb1580","doi-asserted-by":"crossref","first-page":"16766","DOI":"10.1021\/acs.jmedchem.5c01619","article-title":"Identification of an unexplored dynamic allosteric site on the activation pathway of the vasopressin V2 receptor","volume":"68","author":"Qiao","year":"2025","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154063_bb1585","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1038\/s41401-025-01603-w","article-title":"Exploring the distinct activation mechanisms of neuromedin B receptor through multiple replica molecular dynamics simulations and Markov state modeling","volume":"46","author":"Li","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154063_bb1590","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41401-024-01385-7","article-title":"Exploring the constitutive activation mechanism of the class A orphan GPR20","volume":"46","author":"Zhang","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154063_bb1595","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1210\/jc.2010-2855","article-title":"The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral density","volume":"96","author":"Fitzpatrick","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154063_bb1600","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/jbmr.3747","article-title":"Treatment of autosomal dominant hypocalcemia type 1 with the calcilytic NPSP795 (SHP635)","volume":"34","author":"Roberts","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.154063_bb1605","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1056\/NEJMc2302708","article-title":"Efficacy and safety of encaleret in autosomal dominant hypocalcemia type 1","volume":"389","author":"Gafni","year":"2023","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026040092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026040092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:50:42Z","timestamp":1792011042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026040092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":321,"alternative-id":["S0141813026040092"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154063","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allosteric modulation of ionotropic and G protein-coupled receptors in Alzheimer's disease: A neuroprotective strategy and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154063"}}